ProVen VCT (LON:PVN) Stock Price Down 2.5% - Here's Why
ProVen VCT (LON:PVN - Get Free Report)'s share price was down 2.5% during mid-day trading on Wednesday . The stock traded as low as GBX 58 ($0.78) and last traded at GBX 58 ($0.78). Approximately 767 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 153,330 shares. The stock had previously closed at GBX 59.50 ($0.80).
The company has a market capitalization of £157.79 million, a price-to-earnings ratio of 16.68 and a beta of 0.02. The firm has a 50-day simple moving average of GBX 59.40 and a two-hundred day simple moving average of GBX 59.32.
In other ProVen VCT news, insider James Barbour-Smit purchased 23,376 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was purchased at an average cost of GBX 64 ($0.86) per share, with a total value of £14,960.64 ($20,154.44). Insiders own 0.16% of the company's stock.
ProVen VCT plc is a venture capital trust specializing in emerging growth stage investment,expansion and management buyouts. The fund invests in small and medium sized smaller companies. It does not invest in startups. It seeks to invest in non-qualifying investments including cash, liquidity funds, fixed interest securities, debt and debt related securities in growth companies and non-qualifying venture capital investments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider ProVen VCT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProVen VCT wasn't on the list.
While ProVen VCT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
